Impact Factor: 1.4

Artículos originales \ Editorial

The role of percutaneous tricuspid regurgitation interventions in the current clinical practice: tackling a heterogenous disease

Zach Rozenbaum,a,b Sharon Bruoha,a and Azeem Latiba,c,

aDivision of Cardiology, Montefiore Medical Center, Albert Einstein School of Medicine, New York, NY, United States

bSackler Faculty of Medicine, Tel-Aviv University, Israel

cDivision of Cardiology, Department of Medicine, University of Cape Town, Cape Town, South Africa

REC Interv Cardiol. 2022;4:169-172

Stent delivery during primary angioplasty: speed doesn’t matter

Monica Verdoia,a,b and Giuseppe De Lucab,c,

aDivision of Cardiology Ospedale degli Infermi, ASL Biella, Biella, Italy

bDepartment of Translational Medicine, Università del Piemonte Orientale, Novara, Italy

cDepartment of Cardiology, AOU “Maggiore della Carità”, Novara, Italy

REC Interv Cardiol. 2022;4:87-88

Utility of the pressure guidewire in diabetic patients

Josep Gómez-Laraa,b,, and Rafael Romagueraa,b

aÀrea de Malalties del Cor (Bio-Heart), Hospital Universitari de Bellvitge, L´Hospitalet de Llobregat, Barcelona, Spain

bInstitut de Recerca Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

REC Interv Cardiol. 2022;4:89-90

Small margins and big gains: evidence for angioplasty with cutting or scoring balloons in patients with in-stent restenosis

Laurna McGovern,a,b and Robert A. Byrnea,b,

aCardiovascular Research Institute (CVRI) Dublin, Mater Private Network, Dublin, Ireland

bSchool of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland

REC Interv Cardiol. 2022;4:4-5

Limitations of angiography in the detection of target lesion calcium. No significant differences today compared to 1995

Gary S. Mintz

Cardiovascular Research Foundation, New York, United States

REC Interv Cardiol. 2022;4:1-3

New drug-eluting stents: technological refinement continues

Javier Suárez de Lezo,a, and Pedro Martínb

aServicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain

bServicio de Cardiología, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain

REC Interv Cardiol. 2021;3:247-249

TAVI in nonagenarians, what do we know so far?

Pablo Díez-Villanueva, and Fernando Rivero

Servicio de Cardiología, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain

REC Interv Cardiol. 2021;3:245-246

Colchicine: an emerging treatment for coronary artery disease

Waseem Hijazi,a and Sanjit S. Jollyb,

aDepartment of Medicine, McMaster University, Hamilton, Canada

bMcMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada

REC Interv Cardiol. 2021;3:164-165

Registry-based randomized clinical trials in cardiology: opportunities and challenges

David Erlinge

Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden

REC Interv Cardiol. 2021;3:157-160